Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VBC108 in Advanced Solid Tumors
NCT07700160Phase 2Recruiting
- Sponsor
- VelaVigo
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Countries
- 3
01
Overview
A Phase 2 trial of VBC108 in solid tumor, sponsored by VelaVigo. Started Jul 2026; status: recruiting.
02
Drugs
VBC108
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07700160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700160.